SAN DIEGO — Medical devices have a solid track record of approval. Risk for failure comes afterward, when the devices go to market, according to speakers on a panel dedicated to the ophthalmology innovation cycle.
“Where medical devices run into tough times is when you have to go and sell it,” Andy Corley, a principal for Yelroc Consulting, said at the Ophthalmology Innovation Summit at ASCRS here.
Because numbers “always look better on paper,” one has to maintain a balance between “optimism, realism and fantasy,” making sure to deliver a financial
Uncategorized